The multistage process of carcinogenesis in human esophageal epithelial cells induced by human papillomavirus

Oncology Reports

Volumn 11, Issue 3, 2004, Pages 647-654

  Shen, Zhong Ying ^a   Xu, Li Yan ^a   Li, En Min ^a   Cai, Wei Jia ^a   Shen, Jian ^a   Chen, Ming Hua ^a   Cen, Shan ^c   Tsao, Sai Wah ^b   Zeng, Yi ^c  

^a SHANTOU UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Carcinogenesis; Esophagus; Human papillomavirus; Immortalization; Malignant transformation

Indexed keywords

AGAR; MESSENGER RNA; MYC PROTEIN; PROTEIN BCL 2; TELOMERASE;

ANIMAL; APOPTOSIS; ARTICLE; BAGG ALBINO MOUSE; CANCER TRANSPLANTATION; CELL CYCLE; CELL DIVISION; CELL LINE; CELL TRANSFORMATION; CHEMISTRY; EPITHELIUM CELL; ESOPHAGUS TUMOR; HUMAN; KARYOTYPING; METABOLISM; MOUSE; MOUSE MUTANT; NUDE MOUSE; PAPILLOMA VIRUS; PATHOLOGY; PHASE CONTRAST MICROSCOPY; PLOIDY; POLYMERASE CHAIN REACTION; TELOMERE; TIME; ULTRASTRUCTURE; VIROLOGY; WESTERN BLOTTING;

AGAR; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL CYCLE; CELL DIVISION; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIAL CELLS; ESOPHAGEAL NEOPLASMS; HUMANS; KARYOTYPING; MICE; MICE, INBRED BALB C; MICE, NUDE; MICE, SCID; MICROSCOPY, PHASE-CONTRAST; NEOPLASM TRANSPLANTATION; PAPILLOMAVIRIDAE; PLOIDIES; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MYC; RNA, MESSENGER; TELOMERASE; TELOMERE; TIME FACTORS;

EID: 4644371692     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.11.3.647     Document Type: Article

References (50)

1. Jeanmart M, Lantuejoul S, Fievet F, Moro D, Sturm N, Brambilla C and Brambilla E: Value of immunohistochemical markers in preinvasive bronchial lesions in risk assessment of lung cancer. Cancer Res 9: 2195-2203, 2003. (Pubitemid 36687643)
2. Chyczewski L, Niklinski J, Chyczewska E, Niklinska W and Naumnik W: Morphological aspects of carcinogenesis in the lung. Lung Cancer 34 (Suppl 2): 517-525, 2001.
3. Kang GH, Lee S, Kim JS and Jung HY: Profile of aberrant CpG island methylation along multistep gastric carcinogenesis. Lab Invest 83: 519-526, 2003. (Pubitemid 36457706)
4. Yasui W, Yokozaki H, Fujimoto J, Naka K, Kuniyasu H and Tahara E: Genetic and epigenetic alterations in multistep carcinogenesis of the stomach. J Gastroenterol 12: 111-115, 2000. (Pubitemid 30229730)
5. Shintani S, Mihara M, Nakahara Y, Kiyota A, Ueyama Y, Matsumura T and Wong DT: Expression of cell cycle control proteins in normal epithelium, premalignant and malignant lesions of oral cavity. Oral Oncol 38: 235-243, 2002. (Pubitemid 34442544)
6. Kang MK and Park NH: Conversion of normal to malignant phenotype: telomere shortening, telomerase activation, and genomic instabiligy during immortalization of human oral keratinocytes. Crit Rev Oral Biol Med 12: 38-54, 2001. (Pubitemid 32374283)
7. Brandau S and Bohle A: Bladder cancer. I. Molecular and genetic basia of carcinogenesis. Eur Urol 39: 491-497, 2001. (Pubitemid 32678962)
8. Kubo Y, Murao K, Matsumoto K and Arase S: Molecular carcinogenesis of squamous cell carcinomas of the skin. J Med Invest 49: 111-117, 2002. (Pubitemid 35452966)
9. Schwab TS, Stewart T, Lehr J, Pienta KJ, Rhim JS and Macoska JA: Phenotypic characterization of immortalized normal and primary tumor-derived human prostate epithelial cell cultures. Prostate 44: 164-171, 2000. (Pubitemid 30419191)
10. Rajan N, Pruden DL, Kaznari H, Cao Q, Anderson BE, Duncan JL and Schaeffer AJ: Characterization of an immortalized human vaginal epithelial cell line. J Urol 163: 616-622, 2000. (Pubitemid 30060536)
11. Ming SC: Cellular and molecular pathology of gastric carcinoma and precursor lesions: a critical review. Gastric Cancer 1: 31-54, 1998.
12. Fusenig NE and Boukamp P: Multiple stages and genetic alterations in immortalization, malignant transformation, and tumor progression of human skin keratinocytes. Mol Carcinog 23: 144-158, 1998. (Pubitemid 28535818)
13. Syrjanen KJ: Histological changes identical to those of condylomatous lesions found in esophageal squamous cell carcinomas. Arch Geschwulstforsch 52: 283-292, 1982.
14. He D, Zhang DK, Lam KY, Ma L, Ngan HY, Liu SS and Tsao SW: Prevalence of HPV infection in esophageal squamous cell carcinoma in Chinese patients and its relationship to the p53 gene mutation. Int J Cancer 72: 959-964, 1997. (Pubitemid 27433558)
15. Sur M and Cooper K: The role of the human papilloma virus in esophageal cancer. Pathology 30: 348-354, 1998. (Pubitemid 28499640)
16. Poljak M, Cerar A and Seme K: Human papillomavirus infection in esophageal carcinomas: a study of 121 lesions using multiple broad-spectrum polymerase chain reactions and literature review. Hum Pathol 29: 266-271, 1998. (Pubitemid 28123924)
17. Shen ZY, Hu SP, Shen J, Lu LC, Tang CZ, Kuang ZS and Zeng Y: Detection of human papillomavirus in esophageal carcinoma. J Med Virol 68: 412-416, 2002.
18. Chang F, Syrjanen S, Shen Q, Cintorino M, Santopietro R, Tosi P and Syrjanen K: Human papillomavirus involvement in esophageal carcinogenesis in the high-incidence area of China. A study of 700 cases by screening and type-specific in situ hybridization. Scand J Gastroenterol 35: 123-130, 2000. (Pubitemid 30216579)
19. Lavergne D and De-Villiers EM: Papillomavirus in esophageal papillomas and carcinomas. Int J Cancer 80: 681-684, 1999. (Pubitemid 29066277)
20. Shen ZY, Cen S, Xu LY, Cai WJ, Chen MH, Shen J and Zeng Y: E6/E7 genes of human papilloma virus type 18 induced immortalization of human fetal esophageal epithelium. Oncol Rep 10: 1431-1436, 2003.
21. Shen ZY, Cen S, Cai WJ, Xu JJ, Ten ZP, Shen J, Hu Z and Zeng Y: Immortalization of human fetal esophageal epithelial cells induced by E6 and E7 genes of human papilloma virus 18. Chin J Exp Clin Virol 13: 121-123, 1999.
22. Shen ZY, Shen J, Cai WJ, Cen S and Zeng Y: Biological characteristics of human fetal esophageal epithelial cell line immortalized by the E6 and E7 gene of HPV type 18. Chin J Exp Clin Virol 13: 209-212, 1999.
23. Shen ZY, Xu LY, Chen MH, Shen J, Cai WJ and Zeng Y: Progressive transformation of immortalized esophageal epithelial cells. World J Gastroenterol 8: 976-981, 2002. (Pubitemid 35446405)
24. Shen ZY, Shen J, Cai WJ, Chen JY and Zeng Y: Identification of malignant transformation in the immortalized esophageal epithelial cells. Chin J Oncol 24: 107-109, 2002.
25. Dong Z, Cmarik JL, Wendel EJ and Colburn NH: Differential transformation efficiency but not AP-1 induction under anchorage-dependent and -independent conditions. Carcinogenesis 15: 1001-1004, 1994. (Pubitemid 24156902)
26. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL and Shay JW: Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015, 1994.
27. Farwell DG, Shera KA, Koop JI, Bonnet GA, Matthews CP, Reuther GW, Coltrera MD, McDougall JK and Klingelhutz AJ: Genetic and epigenetic changes in human epithelial cells immortalized by telomerase. Am J Pathol 156: 1537-1547, 2000. (Pubitemid 30646693)
28. Shen ZY, Cen S, Shen J, Cai WJ, Xu JJ, Teng ZP, Hu Z and Zeng Y: Study of immortalization and malignant transformation of human embryonic esophageal epithelial cells induced by HPV18E6E7. J Cancer Res Clin Oncol 126: 589-594, 2000.
29. Shen ZY, Xu LY, Chen MH, Cai WJ, Shen J, Ceng JY and Zeng Y: Cytogenetic and molecular genetic changes in malignant transformation of immortalized esophageal epithelial cells. Int J Mol Med 12: 219-224, 2003.
30. Shen ZY, Xu LY, Chen XH, Cai WJ, Shen J, Chen JY, Huang TH and Zeng Y: The genetic events of HPV-immortalized esophageal epithelium cells. Int J Mol Med 8: 537-542, 2001.
31. Duesberg P and Li R: Multistep carcinogenesis: a chain reaction of aneuploidizations. Cell Cycle 2: 202-210, 2003.
32. De-Miglio MR, Simile MM, Muroni MR, Pusceddu S, Calvisi D, Carru A, Seddaiu MA, Daino L, Deiana L, Pascale RM and Feo F: Correlation of c-myc overexpression and amplification with progression of preneoplastic liver lesions to malignancy in the poorly susceptible Wistar rat strain. Mol Carcinog 25: 21-29, 1999. (Pubitemid 29228305)
33. Tarapore P and Fukasawa K: p53 mutation and mitotic infidelity. Cancer Invest 18: 148-155, 2000. (Pubitemid 30118408)
34. Adams JM and Cory S: The Bcl-2 protein family: arbiters of cell survival. Science 281: 1322-1326, 1998. (Pubitemid 28406819)
35. Mutter GL, Wada H, Faquin WC and Enomoto T: K-ras mutations appear in the premalignant phase of both microsatellite stable and unstable endometrial carcinogenesis. Mol Pathol 52: 257-262, 1999. (Pubitemid 29469917)
36. Chin L, Tam A, Pomerantz J, Wong M, Holash J, Bardeesy N, Shen Q, O'Hagan R, Pantginis J, Zhou H, Horner JW II, Cordon-Cardo C, Yanwpoulos GD and Depinho RA: Essential role for oncogenic Ras in tumor maintenance. Nature 400: 468-472, 1999. (Pubitemid 29361802)
37. Weitzman JB and Yaniv M: Rebuilding the road to cancer. Nature 400: 401-402, 1999. (Pubitemid 29361775)
38. Duensing S, Lee LY, Duensing A, Basile J, Piboonniyom S, Gonzalez S, Crum CP and Munger K: The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle. Proc Natl Acad Sci USA 97: 10002-10007, 2000.
39. Villa LL: Human papillomaviruses and cervical cancer. Adv Cancer Res 71: 321-341, 1997.
40. Weijerman PC, van Drunen E, Konig JJ, Teubel W, Romijn JC, Schroder FH and Hagemeijer A: Specific cytogenetic aberrations in two novel human prostatic cell lines immortalized by human papillomavirus type 18 DNA. Cancer Genet Cytogenet 99: 108-115, 1997. (Pubitemid 27514980)
41. Mullokandov MR, Kholodilov NG, Atkin NB, Burk RD, Johnson AB and Klinger HP: Genomic alterations in cervical carcinoma: losses of chromosome heterozygosity and human papilloma virus tumor status. Cancer Res 56: 197-205, 1996. (Pubitemid 26010400)
42. Pfeffer A, Schubbert R, Orend G, Hilger-Eversheim K and Doerfler W: Integrated viral genomes can be lost from adenovirus type 12-induced hamster tumor cells in a clone-specific, multistep process with retention of the oncogenic phenotype. Virus Res 59: 113-127, 1999. (Pubitemid 29069058)
43. Choo KB, Chen CM, Han CP, Cheng WT and Au LC: Molecular analysis of cellular loci disrupted by papillomavirus 16 integration in cervical cancer: frequent viral integration in topologically destabilized and transriptionally active chromosomal regions. J Med Virol 49: 15-22, 1996.
44. Demers GW, Halbert CL and Galloway DA: Elevated wild-type p53 protein levels in human epithelial cell lines immortalized by the human papillomavirus type 16 E7 gene. Virology 198: 169-174, 1994.
45. Boyer SN, Wazer DE and Band V: E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res 56: 4620-4624, 1996. (Pubitemid 26338060)
46. Itakura M, Mori S, Park NH and Bonavida B: Both HPV and carcinogen contribute to the development of resistance to apoptosis during oral carcinogenesis. Int J Oncol 16: 591-597, 2000.
47. Shen ZY, Xu LY, Li C, Cai WJ, Shen J, Chen JY and Zeng Y: A comparative study of telomerase activity and malignant phenotype in multistage carcinogenesis of esophageal epithelial cells induced by human papillomavirus. Int J Mol Med 8: 633-639, 2001.
48. Klingelhutz AJ, Foster SA and McDougall JK: Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 380: 79-82, 1996. (Pubitemid 26076241)
49. Song S, Pitot HC and Lambert PF: The human papillomavirus type 16 E6 gene alone is sufficient to induce carcinomas in transgenic animals. J Virol 73: 5887-5893, 1999. (Pubitemid 29274875)
50. Zur Hausen H: Immortalization of human cells and their malignant conversion by high risk human papillomavirus genotypes. Semin Cancer Biol 9: 405-411, 1999.